HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary Hypertension and Obesity: Focus on Adiponectin.

Abstract
Pulmonary hypertension is an umbrella term including many different disorders causing an increase of the mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg. Recent data revealed a strong association between obesity and pulmonary hypertension. Adiponectin is a protein synthetized by the adipose tissue with pleiotropic effects on inflammation and cell proliferation, with a potential protective role on the pulmonary vasculature. Both in vivo and in vitro studies documented that adiponectin is an endogenous modulator of NO production and interferes with AMP-activated protein kinase (AMPK) activation, mammalian target of rapamycin (mTOR), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κβ) signaling preventing endothelial dysfunction and proliferation. Furthermore, adiponectin ameliorates insulin resistance by mediating the biological effects of peroxisome proliferator-activated receptor-gamma (PPARγ). Therefore, adiponectin modulation emerged as a theoretical target for the treatment of pulmonary hypertension, currently under investigation. Recently, consistent data showed that hypoglycemic agents targeting PPARγ as well as renin⁻angiotensin system inhibitors and mineralocorticoid receptor blockers may influence pulmonary hemodynamics in different models of pulmonary hypertension.
AuthorsFabio Perrotta, Ersilia Nigro, Mariano Mollica, Adriano Costigliola, Vito D'Agnano, Aurora Daniele, Andrea Bianco, Germano Guerra
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 20 Issue 4 (Feb 20 2019) ISSN: 1422-0067 [Electronic] Switzerland
PMID30791536 (Publication Type: Journal Article, Review)
Chemical References
  • Adiponectin
  • Biomarkers
Topics
  • Adiponectin (antagonists & inhibitors, genetics, metabolism)
  • Animals
  • Biomarkers
  • Disease Susceptibility
  • Humans
  • Hypertension, Pulmonary (drug therapy, etiology, metabolism, physiopathology)
  • Molecular Targeted Therapy
  • Myocytes, Smooth Muscle (metabolism)
  • Obesity (complications, genetics, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: